Exact Sciences Corp. (NASDAQ: EXAS), a leader in advanced cancer diagnostics, showcased new data supporting its cancer tests and treatment guidance tools in nine poster presentations and five e-abstracts at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting, held June 3-7 in Chicago, Illinois.Continue reading
Category Archives: AZBio News
Immune recognition of self and non-self explored in new study
In a new study, Arizona State University researcher Joshua LaBaer and his colleagues explore components of the immune system known as autoantibodies. While they have been implicated as central players in a range of serious autoimmune diseases, the study observes that autoantibodies are also found in healthy individuals.Continue reading
Humabiologics and REGEMAT 3D partner to provide printable human-derived biomaterials to the European Market
Humabiologics, an industry leader in providing human-derived biomaterials for regenerative medicine, and REGEMAT 3D, a company at the forefront of personalized biofabrication solutions, announce they have entered into a non-exclusive distribution agreement to respond to the growing demand and serve a broader life sciences customer base of industry partners and academic institutions in the European bioprinting and drug testing market.Continue reading
Moreno to Lead All of Us Research Program University of Arizona-Banner Health
Dr. Francisco Moreno will direct the program’s vision and operations as the primary liaison between the UArizona-Banner team and the National Institutes of Health.Continue reading
C-Path Launches Unique Translational Therapeutics Accelerator with Support from Cottrell Foundation
The global accelerator will transform academic discoveries to drug development opportunitiesContinue reading
Iron Horse Diagnostics is now nVector
Expanding offerings to include CNS gene therapy, diagnostics, and biomarker servicesContinue reading
Calviri Completes Enrollment of 800 Dogs in a Preventative Cancer Vaccine Trial
PHOENIX, Arizona, healthcare company Calviri, Inc., has completed full enrollment in the Vaccine Against Canine Cancer Study (VACCS), with 800 dogs, making it the largest interventional canine clinical trial in the history of veterinary medicine.Continue reading
Helios Scholars at TGen Marks 16th Year – 45 Students Enter Biomedical Research Internship Program
PHOENIX, Ariz. — June 6, 2022 — Today marks the start of the 16th class of Helios Scholars at TGen, the flagship internship program at the Translational Genomics Research Institute (TGen), part of City of Hope.
Circulating Tumor DNA Guides Chemotherapy Use in Stage II Colon Cancer
The study’s findings suggest a way to identify which patients can avoid unnecessary chemotherapy, with its potentially serious side effects and its expense. Researchers from TGen, a part of City of Hope, contribute to study supporting value of ctDNA in assessing treatment options.Continue reading
What it takes to get Big Pharma Partners interested in a new technology
A new 90-minute recorded program, hosted by the Biotechnology Innovation Organization (BIO), offers insights from top Big Pharma professionals in search & evaluation licensing and venture investing about what it takes to get them interested in a new technology. (Video – May 26, 2022)Continue reading